Krishnan Suma — SEC insider filings

SEC reporting owner CIK 1298711. 31 insider filings on record with FilingPulse; latest filed 2026-09-04.

Transaction summary — filings shown

Covers all 31 filings on record, filed 2020-09-17 to 2026-09-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Krystal Biotech, Inc. (KRYS)President, R&D, Director, 10% owner31—208 legs · 925,000 sh · $129,458,78046

Insider filings — Krishnan Suma

FiledFormIssuerReported transactionsSource
2026-09-044Krystal Biotech, Inc. (KRYS)Sale (S): 520 @ $354.54 · Sale (S): 2,006 @ $355.57 · Sale (S): 3,267 @ $356.37 · Sale (S): 3,962 @ $357.57 · Sale (S): 3,180 @ $358.42 · Sale (S): 3,392 @ $359.39 · +7 moreEDGAR
2026-06-054Krystal Biotech, Inc. (KRYS)Sale (S): 320 @ $300.75 · Sale (S): 593 @ $302.25 · Sale (S): 247 @ $303.17 · Sale (S): 400 @ $304.89 · Sale (S): 480 @ $305.87 · Sale (S): 1,348 @ $307.09 · +5 moreEDGAR
2026-03-064Krystal Biotech, Inc. (KRYS)Sale (S): 407 @ $257.32 · Sale (S): 589 @ $258.54 · Sale (S): 668 @ $259.61 · Sale (S): 3,667 @ $260.37 · Sale (S): 2,931 @ $261.41 · Sale (S): 1,938 @ $262.35 · +4 moreEDGAR
2026-03-034Krystal Biotech, Inc. (KRYS)Option exercise (M): 22,500 @ $0 · Tax withholding (F): 10,236 @ $275.64 · Option exercise (M): 4,000 @ $0 · Tax withholding (F): 1,820 @ $275.64 · Option exercise (M): 8,750 @ $0 · Tax withholding (F): 3,981 @ $275.64 · +9 moreEDGAR
2025-12-054Krystal Biotech, Inc. (KRYS)Sale (S): 700 @ $214.25 · Sale (S): 600 @ $215.49 · Sale (S): 1,400 @ $216.97 · Sale (S): 3,593 @ $218.83 · Sale (S): 5,419 @ $219.68 · Sale (S): 2,627 @ $220.52 · +11 moreEDGAR
2025-07-164Krystal Biotech, Inc. (KRYS)Sale (S): 13,335 @ $150.29 · Sale (S): 100 @ $151 · Sale (S): 2,236 @ $150.68 · Sale (S): 800 @ $151.79 · Sale (S): 1,529 @ $150 · Sale (S): 13,400 @ $150.30 · +3 moreEDGAR
2025-07-114Krystal Biotech, Inc. (KRYS)Sale (S): 200 @ $150.14 · Sale (S): 6,500 @ $150.23 · Sale (S): 300 @ $151.39 · Sale (S): 200 @ $150.07 · Sale (S): 6,627 @ $150.22 · Sale (S): 300 @ $151.39EDGAR
2025-03-134Krystal Biotech, Inc. (KRYS)Sale (S): 1,639 @ $175.97 · Sale (S): 4,579 @ $176.88 · Sale (S): 10,937 @ $177.66 · Sale (S): 6,514 @ $178.76 · Sale (S): 1,331 @ $179.55 · Sale (S): 1,100 @ $175.83 · +4 moreEDGAR
2025-02-284Krystal Biotech, Inc. (KRYS)Tax withholding (F): 3,286 @ $176.39 · Option exercise (M): 7,500 @ $0 · Tax withholding (F): 3,471 @ $179.25 · Option exercise (M): 22,500 @ $0 · Tax withholding (F): 10,414 @ $179.25 · Option exercise (M): 12,500 @ $0 · +10 moreEDGAR
2024-12-134Krystal Biotech, Inc. (KRYS)Sale (S): 5,942 @ $163.04 · Sale (S): 8,923 @ $163.92 · Sale (S): 4,723 @ $164.91 · Sale (S): 2,114 @ $165.79 · Sale (S): 798 @ $166.96 · Sale (S): 200 @ $168.31 · +11 moreEDGAR
2024-09-134Krystal Biotech, Inc. (KRYS)Sale (S): 8,497 @ $195.43 · Sale (S): 2,727 @ $196.07 · Sale (S): 1,385 @ $197.55 · Sale (S): 3,392 @ $198.43 · Sale (S): 2,945 @ $199.22 · Sale (S): 4,159 @ $200.41 · +9 moreEDGAR
2024-06-114Krystal Biotech, Inc. (KRYS)Sale (S): 900 @ $171.40 · Sale (S): 2,099 @ $172.24 · Sale (S): 1,206 @ $173.41 · Sale (S): 1,724 @ $174.50 · Sale (S): 4,975 @ $175.33 · Sale (S): 5,867 @ $176.38 · +10 moreEDGAR
2024-03-114Krystal Biotech, Inc. (KRYS)Sale (S): 2,658 @ $168.15 · Sale (S): 1,646 @ $168.96 · Sale (S): 8,040 @ $170.42 · Sale (S): 5,469 @ $171.09 · Sale (S): 2,800 @ $172.21 · Sale (S): 3,587 @ $173.30 · +8 moreEDGAR
2024-03-014Krystal Biotech, Inc. (KRYS)Option exercise (M): 7,500 @ $0 · Tax withholding (F): 3,471 @ $163.08 · Option exercise (M): 12,500 @ $0 · Tax withholding (F): 5,785 @ $163.08 · Option exercise (M): 7,500 (derivative) @ $0 · Grant/award (A): 45,000 (derivative) @ $0EDGAR
2024-02-284Krystal Biotech, Inc. (KRYS)Tax withholding (F): 2,353 @ $157EDGAR
2023-12-124Krystal Biotech, Inc. (KRYS)Sale (S): 2,854 @ $104.26 · Sale (S): 4,541 @ $105.06 · Sale (S): 17,505 @ $106.04 · Sale (S): 100 @ $107.66 · Sale (S): 4,400 @ $104.41 · Sale (S): 6,263 @ $105.50 · +2 moreEDGAR
2023-09-124Krystal Biotech, Inc. (KRYS)Sale (S): 5,007 @ $125.23 · Sale (S): 5,452 @ $126.17 · Sale (S): 1,874 @ $127.18 · Sale (S): 10,557 @ $128.37 · Sale (S): 2,110 @ $129.10 · Sale (S): 5,008 @ $125.23 · +4 moreEDGAR
2023-06-024Krystal Biotech, Inc. (KRYS)Sale (S): 20,143 @ $115.98 · Sale (S): 4,557 @ $116.86 · Sale (S): 300 @ $117.57 · Sale (S): 18,884 @ $116.00 · Sale (S): 5,716 @ $116.95 · Sale (S): 400 @ $117.61EDGAR
2023-04-184Krystal Biotech, Inc. (KRYS)Sale (S): 1,050 @ $85.55 · Sale (S): 4,297 @ $86.80 · Sale (S): 9,429 @ $87.41 · Sale (S): 9,724 @ $88.41 · Sale (S): 500 @ $89.12 · Sale (S): 1,050 @ $85.55 · +4 moreEDGAR
2023-02-284Krystal Biotech, Inc. (KRYS)Tax withholding (F): 3,057 @ $78.46 · Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0EDGAR
2023-01-194Krystal Biotech, Inc. (KRYS)Sale (S): 20,617 @ $80.70 · Sale (S): 1,186 @ $81.41 · Sale (S): 345 @ $82.72 · Sale (S): 20,617 @ $80.70 · Sale (S): 1,186 @ $81.41 · Sale (S): 346 @ $82.71 · +4 moreEDGAR
2023-01-054Krystal Biotech, Inc. (KRYS)Sale (S): 3,938 @ $80.09 · Sale (S): 3,748 @ $80.08EDGAR
2023-01-034Krystal Biotech, Inc. (KRYS)Sale (S): 7,484 @ $80.30 · Sale (S): 528 @ $81.10 · Sale (S): 7,447 @ $80.28 · Sale (S): 563 @ $81.11 · Sale (S): 1,700 @ $80.33 · Sale (S): 1,700 @ $80.33EDGAR
2022-12-204Krystal Biotech, Inc. (KRYS)Sale (S): 10,527 @ $80.10 · Sale (S): 10,572 @ $80.10EDGAR
2022-11-284Krystal Biotech, Inc. (KRYS)Sale (S): 4 @ $80.01EDGAR
2022-11-104Krystal Biotech, Inc. (KRYS)Sale (S): 823 @ $80.04 · Sale (S): 966 @ $80.05EDGAR
2022-08-094Krystal Biotech, Inc. (KRYS)Sale (S): 8,992 @ $80.22 · Sale (S): 13,432 @ $81.62 · Sale (S): 2,576 @ $82.20 · Sale (S): 9,088 @ $80.24 · Sale (S): 13,058 @ $81.61 · Sale (S): 2,854 @ $82.19EDGAR
2022-03-014Krystal Biotech, Inc. (KRYS)Tax withholding (F): 3,282 @ $62.50 · Grant/award (A): 50,000 (derivative) @ $0EDGAR
2021-12-144Krystal Biotech, Inc. (KRYS)Sale (S): 100,000 @ $70.50EDGAR
2021-03-024Krystal Biotech, Inc. (KRYS)Grant/award (A): 28,400 · Grant/award (A): 42,600 (derivative) @ $0EDGAR
2020-09-174Krystal Biotech, Inc. (KRYS)Sale (S): 14,435 @ $46.21 · Sale (S): 1,517 @ $47.15 · Sale (S): 9,749 @ $46.24 · Sale (S): 5,142 @ $46.85 · Sale (S): 10,594 @ $46.09 · Sale (S): 7,437 @ $46.63 · +1 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1298711 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs